Aflac (AFL) valuation

Life & Health Insurance · NYSE · Financials

$123.89 +0.28% Close Oct 30, 2026 Live

Aflac P/E ratio history

Aflac trades at 13.4 times its earnings over the last twelve months and 16.9 times the earnings analysts expect over the next twelve.

n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.

Aflac valuation against its peers

At the close on Oct 30, 2026.
CompanyMarket valueP/EForward P/E
AflacAFL $63.1B 13.416.9
MetLifeMET $64.4B 19.19.4
Prudential FinancialPRU $40.4B 10.68.4
Principal Financial GroupPFG $23.9B 12.411.2
Globe LifeGL $12.4B 10.69.9
Peer median11.59.6

Reading these multiples

The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.

See also: AFL returns

No forecast, no recommendation. This page describes Aflac from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.